Abstract
Neuropathic pain following nerve injury is a chronic disease characterized by allodynia and hyperalgesia of either mechanical or thermal origin. The mechanism underlying this disease is poorly understood leading to pharmacologic and physiotherapeutic control that is often insufficient. In this chapter, we describe a method to induce nerve injury in rats to create a robust animal model for studying neuropathic pain. Additionally we describe a method to follow up on animals in the process of testing treatments for efficacy in alleviating allodynia by testing for both mechanical and thermal allodynia with reproducible results.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Baron R, Binder A, Wasner G (2010) Neuropathic pain. Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9:807–819
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 10:287–333
Kuner R (2010) Central mechanisms of pathological pain. Nat Med 16:1258–1266
Tanga FY, Raghavendra V, DeLeo JA (2007) Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45:397–407
Brines M, Ghezzi P, Keenan S, Agnello D, De Lanorelle N, Cerami A (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97:10531–10536
Liao ZB, Zhi XG, Shi QH, He ZH (2008) Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur J Neurol 15:140–149
Campana MW, Myers RR (2003) Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur J Neurosci 18:1497–1506
Sekiguchi Y, Kikuchi S, Myers RR, Campana WM (2003) Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush. Spine 28:2577–2584
Keswani S, Buldanlioglu U, Fischer A, Reed N, Polley M, Liang H, Zhou C, Jack C, Leitz G, Hoke A (2004) A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol 56:815–826
Campana WM, Li X, Shubayev VI, Angert M, Cai K, Myers RR (2006) Erythropoietin reduces Schwann cell TNF-a, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Eur J Neurosci 23:617–626
Jia H, Feng X, Li W, Hu Y, Zeng Q, Liu J, Xu J (2009) Recombinant human erythropoietin attenuates spinal neuroimmune activation of neuropathic pain in rats. Ann Clin Lab Sci 39:84–91
Jia H, Jin Y, Ji Q, Hu Y, Zhou Z, Xu J, Yang J (2009) Effects of recombinant human erythropoietin on neuropathic pain and cerebral expressions of cytokines and nuclear factor-kappa B. Can J Aneasth 56:597–603
Sasaki N, Sekiguchi M, Kikuchi S, Konno S (2011) Effects of asialo-erythropoietin on pain-related behavior and expression of phosphorylated-P38 MAP kinase and tumor necrosis factor-alpha induced by application of autologous nucleus pulposus on nerve root in rat. Spine 36:E86–E94
Brines M, Patel NSA, Villa P, Brines C, Mennini T, De Paola M, Erbayraktar Z, Erbayraktar S, Sepodes B, Thiemermann C, Ghezzi P, Yamin M, Hand CC, Xie QW, Coleman T, Cerami A (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A 105:10925–10930
Swartjes M, Morariu A, Niesters M, Brines M, Cerami A, Aarts L, Dahan A (2011) ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain. An experimental study in rats and β-common receptor knockout mice. Anesthesiology 115:1084–1092
Sigtermans M, van Hilten JJ, Bauer M, Arbous M, Marinus J, Sarton E, Dahan A (2009) Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain 145:304–311
Swartjes M, Morariu A, Niesters M, Aarts L, Dahan A (2011) Nonselective and NR2B-selective N-methyl-d-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain. Anesthesiology 115:165–174
Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149–158
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Swartjes, M., Niesters, M., Dahan, A. (2013). Assessment of Allodynia Relief by Tissue-Protective Molecules in a Rat Model of Nerve Injury-Induced Neuropathic Pain. In: Ghezzi, P., Cerami, A. (eds) Tissue-Protective Cytokines. Methods in Molecular Biology, vol 982. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-308-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-62703-308-4_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-307-7
Online ISBN: 978-1-62703-308-4
eBook Packages: Springer Protocols